Clinical Study of Characteristics of Acute Poisoning Caused by Calcium Channel Blockers

Clinical Study of Characteristics of Acute Poisoning Caused by Calcium Channel Blockers

Background Calcium channel blockers (CCBs) are the most commonly used class of antihypertensive drugs in China. Despite the high mortality rate of severe CCBs poisoning, few relevant reports on its clinical characteristics can be found currently. Objective To analyze the clinical characteristics of...

Full description

Bibliographic Details
Main Author:	LI Hui, REN Zhen, GUO Zhiguo
Format:	Article
Language:	zho
Published:	Chinese General Practice Publishing House Co., Ltd 2023-05-01
Series:	Zhongguo quanke yixue
Subjects:	calcium channel blockers\|poisoning\|plasma concentration\|blood purification\|clinical score\|shock\|extracorporeal membrane pulmonary oxygenation
Online Access:	https://www.chinagp.net/fileup/1007-9572/PDF/zx20220798.pdf

Similar Items

Successful treatment of severe calcium channel blocker poisoning, new experience with the guidance of invasive hemodynamic monitoring in a 17-year-old girl: a case report
by: Amir Saeed, et al.
Published: (2024-02-01)

The Long-term Response to Treatment with Calcium Channel Blockers in Patients with Idiopathic Pulmonary Arterial Hypertension
by: Azam Kiani, et al.
Published: (2023-01-01)

Loss of response to calcium channel blockers after long-term follow-up treatment in patients with idiopathic pulmonary arterial hypertension
by: Bruna Piloto, et al.
Published: (2023-05-01)

Corrected QT interval in electrocardiogram recordings in patients treated with calcium channel blockers
by: Małgorzata Wołek, et al.
Published: (2023-06-01)

Calcium-channel blockers for the prevention of stroke: from scientific evidences to the clinical practice
by: S. Taddei
Published: (2013-05-01)

Calcium channel blockers- Induced iatrogenic gingival hyperplasia: Case series
by: G Agnes Golda Priyadarshini, et al.
Published: (2023-01-01)

N-/T-Type vs. L-Type Calcium Channel Blocker in Treating Chronic Kidney Disease: A Systematic Review and Meta-Analysis
by: Mingming Zhao, et al.
Published: (2023-02-01)

Central ECMO cannulation for severe dihydropyridine calcium channel blocker overdose
by: Cardenas Jose M., et al.
Published: (2023-12-01)

Penggunaan Calcium Channel Blocker pada Tatalaksana Anestesi Clipping Aneurisma Otak
by: Fanda Ayyu Rindiati, et al.
Published: (2019-10-01)

HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
by: O. A. Kislyak, et al.
Published: (2017-07-01)

Case report: Pathological differences in pulmonary arterial hypertension in long-term responders to calcium channel blockers
by: Yuichi Tamura, et al.
Published: (2023-11-01)

Calcium channel blockers and clinical outcomes in patients with continuous‐flow left ventricular assist devices
by: Hongtao Tie, et al.
Published: (2024-02-01)

QuEChERS-Based Approach to the Extraction of Five Calcium Channel Blockers from Plasma Determined by UPLC-MS/MS
by: Tingting Zhao, et al.
Published: (2023-01-01)

POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY
by: Yu. V. Lukina, et al.
Published: (2016-01-01)

Neuroprotective effect of the calcium channel blocker nilvadipine on retinal ganglion cell death in a mouse ocular hypertension model
by: Hidekazu Tsuruga, et al.
Published: (2023-03-01)

Calcium Channels in the Heart: Disease States and Drugs
by: Kajol Shah, et al.
Published: (2022-03-01)

Synthesis, Evaluation of Vasorelaxant Activity, and Molecular Docking of Pyranopyrazole Derivatives as Calcium Channel Blockers
by: Saghar Mowlazadeh Haghighi, et al.
Published: (2023-06-01)

Diindolylmethane Derivatives: New Selective Blockers for T-Type Calcium Channels
by: Dan Wang, et al.
Published: (2022-07-01)

Intrapleural and Intraperitoneal Free Fluid in Calcium Channel Blocker Overdose
by: Mustafa Yılmaz, et al.
Published: (2016-06-01)

Calcium Channel Blockers Are Associated with Nocturia in Men Aged 40 Years or Older
by: Satoshi Washino, et al.
Published: (2021-04-01)

Effect of calcium-channel blockers on the risk of active tuberculosis and mortality: systematic review and meta-analysis
by: Edinson Dante Meregildo-Rodriguez, et al.
Published: (2024-01-01)

Investigation into in vitro anti-leishmanial combinations of calcium channel blockers and current anti-leishmanial drugs
by: Juliana Quero Reimão, et al.
Published: (2011-12-01)

Design, Synthesis, Pharmacodynamic and <i>In Silico</i> Pharmacokinetic Evaluation of Some Novel Biginelli-Derived Pyrimidines and Fused Pyrimidines as Calcium Channel Blockers
by: Ahmed M. Farghaly, et al.
Published: (2022-03-01)

Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients
by: Ema Rastoder, et al.
Published: (2023-07-01)

Extracorporeal Hyperoxygenation Therapy (EHT) for Carbon Monoxide Poisoning: In-Vitro Proof of Principle
by: Niklas B. Steuer, et al.
Published: (2021-12-01)

Calcium Channel Blocker Use and the Risk for Breast Cancer: A Population-Based Nested Case-Control Study
by: Victoria Rotshild, et al.
Published: (2022-05-01)

Cardiovascular outcomes of β‐blocker—calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real‐world retrospective study
by: Junxiong Lin, et al.
Published: (2023-05-01)

Emergency resuscitation extracorporeal membrane oxygenation (ER ECMO) in 60 saves life
by: Gowtham Vijayakumar, et al.
Published: (2023-01-01)

Calcium channel blocker and risk of postoperation lymphatic-related complications among gynecologic malignances
by: Haote Jiang, et al.
Published: (2023-01-01)

Vasoplegia and pulmonary edema in mixed overdose of antihypertensive drugs: a case report
by: Diana Lizeth Cabrera Rojas, et al.
Published: (2023-07-01)

Chyloperitoneum in Peritoneal Dialysis Secondary to Calcium Channel Blocker Use: Case Series and Literature Review
by: Luca Piscitani, et al.
Published: (2023-03-01)

TREATMENT OF ESSENTIAL HYPERTENSION WITH CALCIUM CHANNEL BLOCKERS: WHAT IS THE PLACE OF LERCANIDIPINE
by: Michel Burnier, et al.
Published: (2010-04-01)

Slow-flow phenomenon after drug-coated balloon angioplasty for lower-extremity arteries is associated with lack of prescribing of calcium channel blockers
by: Yoh Arita, et al.
Published: (2023-01-01)

Calcium-Channel-Blocker-Influenced Gingival Enlargement: A Conundrum Demystified
by: Pallavi Tonsekar, et al.
Published: (2021-08-01)

The Roles of Calcium Ions in Parkinson’s Disease: Calcium Channel Inhibitors as a Novel Agents?
by: Md Reyaz Alam, et al.
Published: (2022-10-01)

Novel protocol for multiple-dose oral administration of the L-type Ca2+ channel blocker isradipine in mice: A dose-finding pharmacokinetic study
by: Tamara Theiner, et al.
Published: (2024-12-01)

Sex Differences in the Anti-Hypertensive Effect of Calcium-Channel Blockers: A Systematic Review and Meta-Analysis
by: Eveline M. van Luik, et al.
Published: (2023-06-01)

The effect of an L/N-type calcium channel blocker on intradialytic blood pressure in intradialytic hypertensive patients
by: Takayasu Ito, et al.
Published: (2019-01-01)

The Cardiogenic Shock with Antihypertensive Drugs Intoxication in a Child
by: Hatice Feray Arı, et al.
Published: (2022-09-01)

TREATMENT OF HYPERTENSIVE PATIENTS WITH HIGH OR VERY HIGH CARDIOVASCULAR RISK. PHARMACOECONOMIC EFFICIENCY OF A TRIPLE COMBINATION THERAPY CONTAINING ANGIOTENSIN CONVERTING ENZYME INHIBITOR, CALCIUM CHANNEL BLOCKER AND STATIN
by: I. N. DYAKOV
Published: (2016-12-01)